New

Global ETF Survey 2026 Available: How 620 Professionals Select ETFs. Access the Report →

Help us improve your experience. Please confirm your investor type:

Global ETF Survey 2026

Access the report

›ETF Issuers›Smart›LIV

LIV

Smart Healthcare Innovation ETF

Passive ETF Equity ESG Theme: Healthcare Technology & Innovation Theme: Tomorrow's Treatments

Not rated

The LIV Exchange Traded Fund (ETF) is provided by Smart. It is built to track an index: STOXX Global Breakthrough Healthcare Index. The dividend policy is capitalization.

NZ$4.29

N/A

Data as of 10/21/26

1D price range

N/A

52W price range

N/A

YTD Perf.

+23.31%

YTD Flows

Annualized volatility

Fund AuM

€16M

Share class AuM

€16M

TTM Yield

Tracking Error

Tracking Difference

Characteristics

ISIN

NZLIVE0008S6

TER

0.75%

Inception date

6/6/2019

Issuer

Smart

Benchmark

STOXX Global Breakthrough Healthcare Index

Replication method

Dividend policy

Capitalization

Compare similar ETFs

ETF Name	1w perf.
2B78 iShares Healthcare Innovation UCITS ETF	+4.26%
IBBQ Invesco Nasdaq Biotechnology ETF	+3.72%
203780 Mirae Asset TIGER NASDAQ BIO ETF	+4.02%
IBB iShares Biotechnology ETF	+4.07%
IDNA iShares Genomics Immunology and Healthcare ETF	+3.06%
HTEC Robo Global Healthcare Technology and Innovation ETF	+2.66%
BTEE iShares Nasdaq US Biotechnology UCITS ETF	+3.72%
XDNA iShares Genomics Immunology and Healthcare Index ETF	+1.59%
XGEN Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF	+4.33%
CIB0 Vaneck Bionic Engineering Ucits ETF	+2.62%
00678 CAPITAL NASDAQ BIOTECHNOLOGY INDEX ETF	+6.45%
DOCG L&G Healthcare Technology & Innovation UCITS ETF	+3.41%
TMED T. Rowe Price Health Care ETF	+4.41%
CURE VanEck Genomics and Healthcare Innovators UCITS ETF	+4.28%
HLTH VanEck Global Healthcare Leaders ETF	+4.04%

API

PerformanceDec 31, 2025 - Oct 21, 2026

Flows

Join for free to unlock

Sector exposures

Data as of 08/31/26

Healthcare

99.59%

Other

1.00%

Latest LIV news

No content available for this fund

FAQ about LIV

LIV is a Passive ETF. This ETF provides exposure to Other Equities.

LIV tracks the STOXX Global Breakthrough Healthcare Index - USD, through a replication method.

LIV carries a total expense ratio (TER) of 0.75%, indicating the annual cost for holding the fund.

LIV was introduced to the market on June 6, 2019. It trades on New Zealand

Smart Healthcare Innovation ETF, LIV, is provided by Smart. Learn more about Smart here.

LIV oversees €16M in assets as of October 21, 2026.

LIV follows a capitalizing, meaning it reinvests income within the fund.

As of August 31, 2026, LIV has significant geographic allocations in USA, Switzerland and Japan.

As of August 31, 2026, LIV focuses largely on Healthcare.

As of August 31, 2026, LIV holds 200 positions in its portfolio, with 25.30% of assets concentrated in its top 15 holdings.

As of August 31, 2026, LIV top three holdings include Moderna, Inc., Natera, Inc. and IQVIA Holdings, Inc..

The base currency of LIV is NZD.

Top 10 holdings

Data as of 08/31/26

Moderna, Inc.

3.63%

Natera, Inc.

1.78%

IQVIA Holdings, Inc.

1.73%

Illumina, Inc.

1.65%

Genmab A/S

1.63%

Amgen, Inc.

1.54%

Merck & Co., Inc.

1.53%

Celltrion, Inc.

1.51%

Guardant Health, Inc.

1.51%

Abbott Laboratories

1.49%

Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:

More fund data
Compare up to 3 funds
More screener filters
Edit screener columns from 100+ metrics
Watchlists for saving your research
Portfolio construction and analysis
Personal dashboard for live monitoring

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight

Smart Healthcare Innovation ETF

FAQ about LIV

Essentials

About Trackinsight

ETF TOOLS

PLATFORM

ETF NEWS & RESEARCH

PROFESSIONAL SOLUTIONS

SOLUTIONS FOR

CONTACT US